Neosante Delictase® Oral Drops, a Lactase Formula to Treat Baby Colic, Coming Soon to RevNutrition.com

Share Article

Neosante Health Solutions is bringing its top-selling Delictase® Oral Drops, a lactase enzyme supplement used to treat baby colic, to health and wellness ecommerce site RevNutrition.com.

Neosante sold more than two million bottles of Delictase® Oral Drops in Europe in 2017, predominately to health-conscious parents coping with colic.

Delictase® helps children digest lactose without disrupting natural processes, such as development of lactase. Lactase is needed for lactose digestion. The solution has just enough lactase to treat hypolactasia, preventing uncomfortable stomach cramping and acidic digestive conditions.

Neosante Health Solutions is bringing its top-selling Delictase® Oral Drops, a lactase enzyme supplement used to treat baby colic, to health and wellness ecommerce site RevNutrition.com.

Colic is an issue affecting up to 40 percent of infants, characterized by excessive crying when the child is between 6 weeks and 6 months old, likely caused by gastrointestinal discomfort and intestinal cramping. This digestive issue is treated by Delictase® Oral Drops, which will be available soon on RevNutrition.com and other ecommerce sites in the coming months as the company expands into the U.S. marketplace.

“Delictase® Oral Drops prevent excess crying in babies by providing enzymes needed for digestion,” Neosante CEO João Santos said. “If you have a baby that cries daily for unknown reasons, Delictase® can be a lifesaver. Most parents do not know what colic is, and that there are treatments available if your child suffers from it.

“Delictase® helps children digest lactose without disrupting natural processes, such as development of lactase. Lactase is needed for lactose digestion. The solution has just enough lactase to treat hypolactasia, preventing uncomfortable stomach cramping and acidic digestive conditions.”

Delictase® Oral Drops come prepackaged in a dropper designed to add the Delictase® solution to breast milk or baby formula. Neosante sold more than two million bottles of Delictase® Oral Drops in Europe in 2017, predominately to health-conscious parents coping with colic. Neosante also sells Delictase® Capsules aimed at lactose intolerant children and adults, which it plans to bring to U.S. consumers at a future date.

“We are an international company with a strong reputation,” Santos said. “While colic rarely lasts more than a year, it has been a persistent problem that is not expected to go away. We provide an affordable, effective solution to colic worldwide.”

Established in 2007, Neosante Health Solutions is a privately owned pharmaceutical company producing food supplements, medical devices and cosmetics. Neosante is based out of Portugal and currently distributing to 20 countries, focusing on bringing its most popular item, Delictase® Oral Drops, to retailers throughout the U.S.

For more information on Neosante products, coming soon to RevNutrition.com, visit http://www.neosante-hs.com/. For more information on Delictase® Oral Drops, visit http://www.delictase.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Shaun Cox
@IHMShaun
Follow >
Visit website